Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
Yet another viral disease of childhood is in sight of control by vaccination. At a workshop held recently at the National Institutes of Health, Bethesda, Md, speakers reported that a chickenpox vaccine that has been widely tested in recent years in immunocompromised persons is safe and immunogenic in normal children and adults. The workshop was sponsored by the Food and Drug Administration's National Center for Drugs and Biologics, the National Institute of Allergy and Infectious Diseases, and the National Cancer Institute. "We are looking at the varicella vaccine as an agent for use in normal, healthy children and susceptible adults as well as immunocompromised children," said Arlene A. McLean, PhD, of Merck, Sharp & Dohme, West Point, Pa. Stephen R. Preblud, MD, of the Centers for Disease Control, Atlanta, told the workshop that about 100 deaths each year are reported from varicella. In children between the ages of 1 to
JAMA – American Medical Association
Published: Oct 28, 1983
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.